Advanced glycation endproducts (AGEs) as uremic toxins
Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel (Review) › Beigetragen › Begutachtung
Beitragende
- Universität Heidelberg
- Technische Universität Dresden
Abstract
Products of non-enzymatic glycation accumulate both in diabetic and non-diabetic patients with renal failure. The increase in concentration is presumably due to increased generation, secondary to oxydative stress and due to decreased (renal) elimination; whether accumulation of AGEs of dietary origin plays a role is currently under investigation. AGE's have been related to progression of diabetic land possibly also non-diabetic) renal disease and to a number of complications of the uremic syndrome. These comprise beta-2-microglobulin-derived dialysis-related amyloidosis, dyslipidemia, vascular dysfunction and accelerated atherogenesis. A specific case is AGE related damage to the peritoneal membrane in CAPD patients. Removal of AGE by dialysis is negligible and even high flux dialysis eliminates only a quantitatively limited amount of AGE. In contrast, a rapid decrease of AGE concentrations in plasma is noted after renal transplantation. Dietary AGEs may contribute significantly to the total AGE load of the body, particularly in uremia.
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 172-176 |
Seitenumfang | 5 |
Fachzeitschrift | Nahrung = Food |
Jahrgang | 45 |
Ausgabenummer | 3 |
Publikationsstatus | Veröffentlicht - Juni 2001 |
Peer-Review-Status | Ja |
Externe IDs
Scopus | 0041735035 |
---|
Schlagworte
Ziele für nachhaltige Entwicklung
Schlagwörter
- HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS, DIALYSIS-RELATED AMYLOIDOSIS, GLYCOSYLATION END-PRODUCTS, CHRONIC-RENAL-FAILURE, DIABETIC NEPHROPATHY, IMMUNOHISTOCHEMICAL DETECTION, MAILLARD REACTION, OXIDATIVE STRESS, BONE-RESORPTION, PLASMA